| 1 |
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. 2005, CA Cancer J Clin, 55(2): 74-108.
|
| 2 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3 |
Borie F, Bouvier AM, Herrero A et al. Treatment and prognosis of hepatocellular carcinoma: A population based study in France [J]. J Surg Oncol, 2008, 98(7): 505-509.
|
| 4 |
张雨康, 牛丽娟, 王勇. 射频消融在肝细胞肝癌临床治疗中的研究现状与进展 [J]. 癌症进展, 2017, 15(1): 15-17, 21.
|
| 5 |
Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors [J]. Ann Surg, 242(2): 158-171.
|
| 6 |
Zuo TY, Liu FY, Wang MQ, et al. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas [J]. Chin Med J (Engl), 2017, 130(22): 2666-2673.
|
| 7 |
Huang G, Lin M, Xie X, et al. Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma [J]. Eur Radiol, 2014, 24(7): 1565-1571.
|
| 8 |
Yang W, Lee JC, Chen MH, et al. Thermosensitive liposomal doxorubicin plus radiofrequency ablation increased tumor destruction and improved survival in patients with medium and large hepatocellular carcinoma: A randomized, double-blinded, dummy-controlled clinical trial in a single center [J]. J Cancer Res Ther, 2019, 15(4): 773-783.
|
| 9 |
Yang W, Yan K, Wu GX, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes [J]. World J Gastroenterol, 2015, 21(5): 1554-1566.
|
| 10 |
Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases [J]. Cancer, 2005, 103(6): 1201-1209.
|
| 11 |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J]. Ann Surg, 2006, 243(3): 321-328.
|
| 12 |
李柱, 乔安意, 王翀, 等. 超声引导下射频消融术治疗肝癌疗效及预后影响因素分析 [J].中国医学物理学杂志, 2017, 34(10): 1058-1063.
|
| 13 |
NCCN. The NCCN Hepatobiliiary cancers clinical practice guidelines in oncology (version 1.2011)[EB/OL]. Fort Washington: NCCN, 2018.
|
| 14 |
Cheng BQ, Jia CQ, Liu CT, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial [J]. JAMA, 2008, 299(14): 1669-1677.
|
| 15 |
陈良, 刘艳芳, 孙勤学, 等. 射频消融联合肝动脉化疗栓塞治疗直径3cm以上原发性肝癌的疗效和影响因素分析 [J]. 现代实用医学, 2019, 31(5): 590-592, 648, 564.
|
| 16 |
Poon RT, Fan ST, Lo CM, et a. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years [J]. Ann Surg, 234(1): 63-70.
|
| 17 |
孟庆雯, 李勇, 胡宝山, 等. 经肝动脉化疗栓塞与射频消融和无水乙醇注入对大肝癌的疗效评价及预后分析 [J]. 介入放射学杂志, 2013, 22(8): 646-649.
|
| 18 |
刘玉海, 王静, 王焕珍, 等. 经皮瘤体内PEI联合射频消融治疗较大肝癌的临床研究 [J/CD]. 中国医学前沿杂志(电子版), 2014, 6(10): 120-122.
|
| 19 |
刘扬, 吕万良, 张强. 脂质体及纳米粒药物递送系统的研究进展 [J]. 中国医学科学院学报, 2006, 28(4): 583-589.
|
| 20 |
Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors：increased tumor destruction with adjuvant liposomal doxorubicin therapy [J]. AJR Am J Roentgenol, 2002, 179(1): 93-101.
|
| 21 |
杨鹏波, 张华. 脂质体的研究新进展 [J]. 浙江中医药大学学报, 2013, 37(7): 936-939．
|
| 22 |
Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer [J]. Expert Opin Pharmacother, 2009, 10(2): 333-343.
|
| 23 |
Hong CW, Chow L, Turkbey EB, et al. Imaging features of radiofrequency ablation with Heat-Deployed liposomal doxorubicinin hepatic tumors [J]. Cardiovasc Intervent Radiol, 2016, 39(3): 409-416.
|
| 24 |
Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release [J]. Cancer Res, 2000, 60(24): 6950-6957.
|
| 25 |
Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised,double-blind, placebo-controlled trial [J]. Lancet Oncol, 2009, 10(1): 25-34.
|
| 26 |
Rimassa L, Santoro A. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial [J]. Expert Rev Anticancer Ther, 2009, 9(6): 739-745.
|
| 27 |
Fukuda H, Numata K, Moriya S, et al. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation-propensity score matching analysis [J]. Radiology, 2014, 272(2): 598-604.
|
| 28 |
Feng X, Xu R, Du X, et al. Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study [J]. Am J Gastroenterol, 2014, 109(12): 1891-1899.
|
| 29 |
Zhu Kangshun, Huang Jingjun, Lai Lisha, et al. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation [J]. Radiology, 2018, 288(1): 300-307.
|
| 30 |
Yuan Hongjun, Lan Yina, Li Xin, et al. Large hepatocellular carcinoma with local remnants after transarterial chemoembolization: treatment by sorafenib combined with radiofrequency ablation or sorafenib alone [J]. Am J Cancer Res, 2019, 9(4): 791-799.
|
| 31 |
Bruix J, Takayama T, Mazzaferro V, et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial [J]. Lancet Oncol, 2015, 16(13): 1344-1354.
|
| 32 |
Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors [J]. J Vasc Interv Radiol, 2003, 14(10): 1267-1274.
|
| 33 |
展翔宇. 人工腹水辅助超声引导下膈顶部肝癌射频消融治疗的临床研究 [D]. 郑州大学, 2018.
|
| 34 |
Inoue T, Minami Y, Chung H, et al. Radiofrequency ablation for hepatocellular carcinoma:Assistant techniques for difficult cases [J]. Oncology, 2010, 78(Suppl 1): 94-101.
|
| 35 |
吴薇, 李荣杰, 杨薇, 等. 经皮射频消融治疗邻近膈顶较大肝癌 [J]. 中国介入影像与治疗学, 2018, 15(1): 15-18.
|
| 36 |
Koda Masahiko, Ueki Masaru, Maeda Yoshiko, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. [J]. AJR Am J Roentgenol, 2004, 183(3): 583-588.
|
| 37 |
韩玥, 张景, 闫东, 等. 人工气胸在CT引导下肝脏膈顶肿瘤微波消融中的应用 [J/CD]. 中国医学前沿杂志(电子版), 2017, 9(5): 119-122.
|
| 38 |
杨海云, 罗葆明. 特殊部位肝癌的超声引导下射频消融治疗 [J/CD]. 中华医学超声杂志(电子版), 2006, 3(1): 61-62.
|
| 39 |
Choi D, Lim HK, Kim MJ, et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract [J]. AJR Am J Roentgenol, 2004, 183(5): 1417-1424.
|
| 40 |
Yamakado Koichiro, Nakatsuka Atsuhiro, Akeboshi Masao, et al. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition [J]. J Vasc Interv Radiol, 2003, 14(9 Pt 1): 1183-1186.
|
| 41 |
Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors [J]. J Vasc Interv Radiol, 2003, 14(10): 1267-1274.
|
| 42 |
Ng KK, Lam CM, Poon RT, et al. Portal vein thrombosis after radiofrequency ablation for recurrent hepatocellular carcinoma [J]. Asian J Surg, 2003, 26(1): 50-53.
|
| 43 |
Curley SA. Radiofrequency ablation of malignant liver tumors [J]. Ann Surgical Oncol, 2003, 10(4): 338-347.
|
| 44 |
Ng KK, Poon RT, Lam CM, et al. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion [J]. Br J Surg, 2006, 93(4): 440-447.
|
| 45 |
Nault JC, Sutter O, Nahon P, et al. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations [J]. J Hepatol, 2018, 68(4): 783-797.
|
| 46 |
Seror O, N’Kontchou G, Nault JC, et al. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results [J]. Radiology, 2016, 280(3): 981.
|
| 47 |
Hocquelet A, Aubé C, Rode A, et al. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC [J]. J Hepatol, 2017, 66(1): 67-74.
|
| 48 |
Kotoh K, Nakamuta M, Morizono S, et al. A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time [J]. Liver Int, 2005, 25(3): 542-547.
|
| 49 |
Song KD, Lee MW, Rhim H, et al. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation [J]. AJR Am J Roentgenol, 2016, 207(5): 1122-1127.
|
| 50 |
Kim R, Kang TW, Cha DI, et al. Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications [J]. Eur Radiol, 2018, 29(2): 654-662.
|
| 51 |
Kang TW, Lim HK, Cha DI. Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives [J]. World J Gastroenterol, 2018, 24(47): 5331-5337.
|
| 52 |
Livraghi T, Goldbery SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiof requency ablation of medium and large lesions [J]. Radiology, 2000, 21(3): 761-768
|
| 53 |
霍苓, 陈敏华, 严昆, 等. 胆囊旁肝肿瘤射频消融治疗附加方法及疗效 [J]. 中华超声影像学杂志, 2005, 14(6): 437-440.
|
| 54 |
Kim SW, Rhim H, Park M, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy [J]. Korean J Radiol, 2009, 10(4): 366-376.
|